Compare SB & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SB | CERT |
|---|---|---|
| Founded | 2007 | 2008 |
| Country | Monaco | United States |
| Employees | 1107 | N/A |
| Industry | Marine Transportation | Retail: Computer Software & Peripheral Equipment |
| Sector | Consumer Discretionary | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 682.2M | 808.9M |
| IPO Year | N/A | 2020 |
| Metric | SB | CERT |
|---|---|---|
| Price | $6.41 | $6.96 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 10 |
| Target Price | $6.00 | ★ $11.67 |
| AVG Volume (30 Days) | 864.5K | ★ 4.8M |
| Earning Date | 05-18-2026 | 05-11-2026 |
| Dividend Yield | ★ 3.03% | N/A |
| EPS Growth | N/A | ★ 87.50 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $418,838,000.00 |
| Revenue This Year | $3.47 | $4.18 |
| Revenue Next Year | $3.61 | $5.39 |
| P/E Ratio | $16.77 | ★ N/A |
| Revenue Growth | N/A | ★ 8.75 |
| 52 Week Low | $3.61 | $4.45 |
| 52 Week High | $7.38 | $13.88 |
| Indicator | SB | CERT |
|---|---|---|
| Relative Strength Index (RSI) | 44.51 | 71.99 |
| Support Level | $6.32 | $5.93 |
| Resistance Level | $6.63 | $7.52 |
| Average True Range (ATR) | 0.27 | 0.41 |
| MACD | -0.04 | 0.17 |
| Stochastic Oscillator | 23.44 | 96.91 |
Safe Bulkers Inc is an international provider of marine drybulk transportation services, transporting bulk cargoes, particularly coal, grain, and iron ore, along international shipping routes for consumers of marine drybulk transportation services. The company employs its vessels on both period time charters and spot time charters, according to the assessment of market conditions, with consumers of marine drybulk transportation services. The company generates almost all of its revenue from Time Charters.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval, and increase patient access to medicines. The company has its business presence in the Americas, which is also its key revenue-generating market, EMEA, and the Asia Pacific region.